Zeus Formulation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -60.82%
(FY 2022)
- Profit -75.47%
(FY 2022)
- Ebitda -75.82%
(FY 2022)
- Net Worth 10.98%
(FY 2022)
- Total Assets -80.82%
(FY 2022)
About Zeus Formulation
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nikhil Desai and Asit Dhruva serve as directors at the Company.
- CIN/LLPIN
U24297MH2012PTC229673
- Company No.
229673
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Apr 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Zeus Formulation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Desai  | Director | 14-Apr-2012 | Current |
| Asit Dhruva | Director | 14-Apr-2012 | Current |
Financial Performance of Zeus Formulation.
Zeus Formulation Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 60.82% decrease. The company also saw a substantial fall in profitability, with a 75.47% decrease in profit. The company's net worth Soared by an impressive increase of 10.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zeus Formulation?
In 2022, Zeus Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zeus Formulation?
Unlock and access historical data on people associated with Zeus Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zeus Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeus Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
